Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia

Thomas Briot; Emilie Roger; Nolwenn Lautram; Alexis Verger; Anne Clavreul; Frédéric Lagarce

doi:10.2147/IJN.S147659

Journal articles

Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia

Thomas Briot ^{1, 2} Emilie Roger ² Nolwenn Lautram ² Alexis Verger ² Anne Clavreul ^{3, 4} Frédéric Lagarce ^{1, 2}

1 Département de Pharmacie [CHU Angers]

2 MINT - Micro et Nanomédecines Translationnelles

3 CRCINA-ÉQUIPE 17 - Design and Application of Innovative Local Treatments in Glioblastoma

CRCINA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers

4 Département de Neurochirurgie [CHU Angers]

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Cancer

Complete list of metadata

Cited literature [46 references] Display Hide Download

https://www.hal.inserm.fr/inserm-01668530
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Wednesday, December 20, 2017 - 10:07:49 AM
Last modification on : Wednesday, April 27, 2022 - 4:22:52 AM

Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia

File

Identifiers

Collections

Citation

Export

Metrics

60

83

Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia

File

Identifiers

Collections

Citation

Export

Share

Metrics

60

83